Atomic force microscopy-based topographical imaging of SARS-CoV-2 as part of a tripartite strategy for RNA virus characterization.

Atomic force microscopy-based topographical imaging of SARS-CoV-2 as part of a tripartite strategy for RNA virus characterization.

Publication date: Dec 09, 2025

Open Access PDF

Concepts Keywords
Atomic Atomic force microscopy
Med RNA virus
Microscopy SARS-CoV-2
Tripartite
Virus

Semantics

Type Source Name
pathway REACTOME Reproduction
disease MESH included
disease MESH COVID 19 pandemic
drug DRUGBANK Tretamine
disease MESH severe acute respiratory syndrome
disease MESH strain
disease MESH image
disease MESH dehydration
drug DRUGBANK Gold
pathway KEGG Virion
disease MESH glass
disease MESH influenza
drug DRUGBANK Propiolactone
drug DRUGBANK Human Serum Albumin
disease MESH IVa
drug DRUGBANK Aspartame
disease MESH FBS
drug DRUGBANK Streptomycin
disease MESH SFM
drug DRUGBANK Sucrose
drug DRUGBANK Flunarizine
drug DRUGBANK L-Leucine
drug DRUGBANK Water
drug DRUGBANK Medical air
drug DRUGBANK Tapentadol
disease MESH Dengue
disease MESH Infection
disease MESH LPI
disease MESH CRC
disease MESH Pneumonia
disease MESH herpes simplex
drug DRUGBANK Ethanol
drug DRUGBANK Edaravone
disease MESH Inflammation

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *